Abstract A040: Intratumor stem cell repertoire in pancreatic cancer
Metastatic pancreatic ductal adenocarcinoma (PDAC) is difficult to manage, has an overall survival of approximately nine months, and will soon be the second leading cause of death among cancers. The poor outcome of PDAC patients has been attributed, in part, to a pattern of intratumor heterogeneity reflected in the g...